Company Filing History:
Years Active: 2017
Title: Sudipta Moitra: Innovator in Pharmaceutical Composition for Lung Cancer Treatment
Introduction
Sudipta Moitra is a notable inventor based in Santiniketan, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lung cancer. His innovative work has the potential to impact the lives of many patients suffering from this disease.
Latest Patents
Sudipta Moitra holds a patent for a synergistic pharmaceutical composition useful for the treatment of lung cancer. The patent describes a composition that includes Compound C2 (Neo-isopulegol), C3 (Iso-pulegol), and C4 (Citronellol), which are derived from herbal seed extracts. This composition has shown effectiveness in killing A549 lung cancer cells, either alone or in combination.
Career Highlights
Sudipta Moitra is associated with the Council of Scientific & Industrial Research, where he conducts research and develops innovative solutions in the pharmaceutical sector. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Some of his notable coworkers include Mantu Bhuyan and Pranab Ram Bhattacharyya, who contribute to the collaborative efforts in research and development within the organization.
Conclusion
Sudipta Moitra's contributions to the field of pharmaceuticals, particularly in developing treatments for lung cancer, highlight his role as an innovator. His patent and ongoing research efforts reflect a dedication to improving healthcare solutions.